Chemical Library Screens Targeting an HIV-1 Accessory factor/Host Cell Kinase Complex Identify Novel Antiretroviral Compounds

被引:61
作者
Emert-Sedlak, Lori [1 ]
Kodama, Toshiaki [1 ]
Lerner, Edwina C. [1 ]
Dai, Weixiang [2 ]
Foster, Caleb [3 ,4 ]
Day, Billy W. [2 ,4 ,5 ]
Lazo, John S. [3 ,4 ]
Smithgall, Thomas E. [1 ,4 ]
机构
[1] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Dept Pharmaceut Sci, Sch Pharm, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA
[4] Univ Pittsburgh, Drug Discovery Inst, Sch Med, Pittsburgh, PA 15261 USA
[5] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA
关键词
LONG-TERM SURVIVOR; CRYSTAL-STRUCTURE; SH3; DOMAINS; NEF PROTEIN; HCK; SRC; ACTIVATION; PATHOGENICITY; INHIBITORS; PROFILES;
D O I
10.1021/cb900195c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nef is an HIV-1 accessory protein essential for AIDS progression and an attractive target for drug discovery. Lack of a catalytic function makes Nef difficult to assay in chemical library screens. We developed a high-throughput screening assay for Inhibitors of Nef function by coupling it to one of its host cell binding partners; the Src-family kinase Hck. Hck activation is dependent upon Nef in this assay, providing a direct readout of Nef activity in vitro. Using this screen; a unique diphenylfuropyrimidine was identified as a strong inhibitor of Nef-dependent Hck activation. This compound also exhibited remarkable antiretroviral effects, blocking Nef-dependent HIV replication in cell culture. Structurally related analogs were synthesized and shown to exhibit similar Nef-dependent antiviral activity, identifying the diphenylfuropyrimidine substructure as a new lead for antiretroviral drug development. This study demonstrates that coupling noncatalytic HIV accessory factors with host cell target proteins addressable by high-throughput assays may afford new avenues for the discovery of anti-HIV agents.
引用
收藏
页码:939 / 947
页数:9
相关论文
共 37 条
[21]   CSF-induced and HIV-1-mediated distinct regulation of Hck and C/EBPβ represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection [J].
Komuro, I ;
Yokota, Y ;
Yasuda, S ;
Iwamoto, A ;
Kagawa, KS .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (03) :443-453
[22]  
LEMER EC, 2002, NAT STRUCT BIOL, V9, P365
[23]   High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection [J].
Mariani, R ;
Kirchhoff, F ;
Greenough, TC ;
Sullivan, JL ;
Desrosiers, RC ;
Skowronski, J .
JOURNAL OF VIROLOGY, 1996, 70 (11) :7752-7764
[24]   Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement [J].
Moarefi, I ;
LaFevreBernt, M ;
Sicheri, F ;
Huse, M ;
Lee, CH ;
Kuriyan, J ;
Miller, WT .
NATURE, 1997, 385 (6617) :650-653
[25]   An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259 [J].
Pene-Dumitrescu, T. ;
Peterson, L. F. ;
Donato, N. J. ;
Smithgall, T. E. .
ONCOGENE, 2008, 27 (56) :7055-7069
[26]   Interactions of HIV-1 Nef with cellular signal transducing proteins [J].
Renkema, GH ;
Saksela, K .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2000, 5 :D268-D283
[27]   Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib, reveal novel kinase and nonkinase targets [J].
Rix, Uwe ;
Hantschel, Oliver ;
Duernberger, Gerhard ;
Rix, Lily L. Remsing ;
Planyavsky, Melanie ;
Fernbach, Nora V. ;
Kaupe, Ines ;
Bennett, Keiryn L. ;
Valent, Peter ;
Colinge, Jacques ;
Kocher, Thomas ;
Superti-Furga, Giulio .
BLOOD, 2007, 110 (12) :4055-4063
[28]   STAUROSPORINE, K-252 AND UCN-01 - POTENT BUT NONSPECIFIC INHIBITORS OF PROTEIN-KINASES [J].
RUEGG, UT ;
BURGESS, GM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (06) :218-220
[29]   PROLINE-RICH (PXXP) MOTIFS IN HIV-1 NEF BIND TO SH3 DOMAINS OF A SUBSET OF SRC KINASES AND ARE REQUIRED FOR THE ENHANCED GROWTH OF NEF(+) VIRUSES BUT NOT FOR DOWN-REGULATION OF CD4 [J].
SAKSELA, K ;
CHENG, GH ;
BALTIMORE, D .
EMBO JOURNAL, 1995, 14 (03) :484-491
[30]   HIV type 1 chemokine receptor usage in mother-to-child transmission [J].
Salvatori, F ;
Scarlatti, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (10) :925-935